These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy. Merga Y; Campbell BJ; Rhodes JM Dig Dis; 2014; 32(4):475-83. PubMed ID: 24969297 [TBL] [Abstract][Full Text] [Related]
23. Upregulation of intestinal mucosal mast cells expressing VPAC1 in close proximity to vasoactive intestinal polypeptide in inflammatory bowel disease and murine colitis. Casado-Bedmar M; Heil SDS; Myrelid P; Söderholm JD; Keita ÅV Neurogastroenterol Motil; 2019 Mar; 31(3):e13503. PubMed ID: 30407703 [TBL] [Abstract][Full Text] [Related]
24. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Macpherson A; Khoo UY; Forgacs I; Philpott-Howard J; Bjarnason I Gut; 1996 Mar; 38(3):365-75. PubMed ID: 8675088 [TBL] [Abstract][Full Text] [Related]
25. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing. Chang J; Leong RW; Wasinger VC; Ip M; Yang M; Phan TG Gastroenterology; 2017 Sep; 153(3):723-731.e1. PubMed ID: 28601482 [TBL] [Abstract][Full Text] [Related]
26. Immunopathogenesis of inflammatory bowel disease: role of cytokines and immune cell-enterocyte interactions. Dionne S; Ruemmele FM; Seidman EG Nestle Nutr Workshop Ser Clin Perform Programme; 1999; 2():41-57; discussion 58-61. PubMed ID: 11490627 [No Abstract] [Full Text] [Related]
27. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection. Stecher B Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088 [TBL] [Abstract][Full Text] [Related]
28. Microbial activation of gut dendritic cells and the control of mucosal immunity. Owen JL; Mohamadzadeh M J Interferon Cytokine Res; 2013 Nov; 33(11):619-31. PubMed ID: 23962004 [TBL] [Abstract][Full Text] [Related]
29. The role of dendritic cells in regulating mucosal immunity and tolerance. Mowat AM; Donachie AM; Parker LA; Robson NC; Beacock-Sharp H; McIntyre LJ; Millington O; Chirdo F Novartis Found Symp; 2003; 252():291-302; discussion 302-5. PubMed ID: 14609226 [TBL] [Abstract][Full Text] [Related]
30. Reduced Dendritic Cells Expressing CD200R1 in Children with Inflammatory Bowel Disease: Correlation with Th17 and Regulatory T Cells. Elshal MF; Aldahlawi AM; Saadah OI; McCoy JP Int J Mol Sci; 2015 Dec; 16(12):28998-9010. PubMed ID: 26690123 [TBL] [Abstract][Full Text] [Related]
31. Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients. Rosen MJ; Karns R; Vallance JE; Bezold R; Waddell A; Collins MH; Haberman Y; Minar P; Baldassano RN; Hyams JS; Baker SS; Kellermayer R; Noe JD; Griffiths AM; Rosh JR; Crandall WV; Heyman MB; Mack DR; Kappelman MD; Markowitz J; Moulton DE; Leleiko NS; Walters TD; Kugathasan S; Wilson KT; Hogan SP; Denson LA Gastroenterology; 2017 May; 152(6):1345-1357.e7. PubMed ID: 28132889 [TBL] [Abstract][Full Text] [Related]
32. Proteomic analysis of the inflamed intestinal mucosa reveals distinctive immune response profiles in Crohn's disease and ulcerative colitis. Berndt U; Bartsch S; Philipsen L; Danese S; Wiedenmann B; Dignass AU; Hämmerle M; Sturm A J Immunol; 2007 Jul; 179(1):295-304. PubMed ID: 17579049 [TBL] [Abstract][Full Text] [Related]
33. Understanding Endoscopic Disease Activity in IBD: How to Incorporate It into Practice. Christensen B; Rubin DT Curr Gastroenterol Rep; 2016 Jan; 18(1):5. PubMed ID: 26759147 [TBL] [Abstract][Full Text] [Related]
37. Intestinal Dendritic Cells in Health and Gut Inflammation. Stagg AJ Front Immunol; 2018; 9():2883. PubMed ID: 30574151 [TBL] [Abstract][Full Text] [Related]